Literature DB >> 24728535

Optic neuritis in Hong Kong: a 1-year follow-up study.

Patrick P K Lau1, Gordon S K Yau, Jacky W Y Lee, Winnie W Y Wong, Victor T Y Tam, Eric Y T Chan, Doris M W Tse, Can Y F Yuen.   

Abstract

To investigate the etiology and prevalence of optic neuritis in a Chinese population. This was a single centre prospective cohort study. Consecutive patients with either a first or recurrent attack of optic neuritis from November 2010 to December 2011 were recruited from a district hospital in Hong Kong Special Administrative Region, China. All patients underwent serology testing for NMO (neuromyelitis optica) IgG; oligoclonal bands from lumbar puncture; computer tomography and contrast magnetic resonance imaging (MRI) of the brain and orbit as well as visual field; and optical coherence tomography testing. Patients were followed up for 1 year after the initial attack. 30 optic neuritis subjects were recruited. 73.3 % (22/30) remain as clinical isolated syndrome (CIS) after 1-year follow-up. 10 % (3/30) patients developed multiple sclerosis. 10 % (3/30) were diagnosed with NMO and 6.7 % (2/30) with NMO-spectrum disorder. The majority of acute unilateral optic neuritis in Chinese was CIS in origin although a fraction does progress to develop MS or NMO-related disorders. Clinicians should be aware of the associations and offer appropriate systemic workups.

Entities:  

Mesh:

Year:  2014        PMID: 24728535     DOI: 10.1007/s10792-014-9945-5

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  30 in total

Review 1.  The prevalence of multiple sclerosis in the world: an update.

Authors:  G Rosati
Journal:  Neurol Sci       Date:  2001-04       Impact factor: 3.307

2.  Azathioprine: tolerability, efficacy, and predictors of benefit in neuromyelitis optica.

Authors:  C Costanzi; M Matiello; C F Lucchinetti; B G Weinshenker; S J Pittock; J Mandrekar; P Thapa; A McKeon
Journal:  Neurology       Date:  2011-08-03       Impact factor: 9.910

Review 3.  Management of optic neuritis as a clinically first event of multiple sclerosis.

Authors:  Nilufer Kale
Journal:  Curr Opin Ophthalmol       Date:  2012-11       Impact factor: 3.761

4.  Revised diagnostic criteria for neuromyelitis optica.

Authors:  D M Wingerchuk; V A Lennon; S J Pittock; C F Lucchinetti; B G Weinshenker
Journal:  Neurology       Date:  2006-05-23       Impact factor: 9.910

5.  Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder?

Authors:  Su-Hyun Kim; Woojun Kim; Xue Feng Li; In-Ja Jung; Ho Jin Kim
Journal:  Mult Scler       Date:  2012-02-21       Impact factor: 6.312

6.  Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.

Authors: 
Journal:  Lancet       Date:  1998-11-07       Impact factor: 79.321

7.  NMO-IgG and Devic's neuromyelitis optica: a French experience.

Authors:  Romain Marignier; Jérôme De Sèze; Sandra Vukusic; Françoise Durand-Dubief; Hélène Zéphir; Patrick Vermersch; Philippe Cabre; Gaëlle Cavillon; Jérôme Honnorat; Christian Confavreux
Journal:  Mult Scler       Date:  2008-01-21       Impact factor: 6.312

Review 8.  Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis.

Authors:  M Clerico; F Faggiano; J Palace; G Rice; M Tintorè; L Durelli
Journal:  Cochrane Database Syst Rev       Date:  2008-04-16

Review 9.  Optical coherence tomography in optic neuritis and multiple sclerosis: a review.

Authors:  K Kallenbach; J Frederiksen
Journal:  Eur J Neurol       Date:  2007-08       Impact factor: 6.089

10.  Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients.

Authors:  Anu Jacob; Brian G Weinshenker; Ivo Violich; Nancy McLinskey; Lauren Krupp; Robert J Fox; Dean M Wingerchuk; Mike Boggild; Cris S Constantinescu; Aaron Miller; Tracy De Angelis; Marcelo Matiello; Bruce A C Cree
Journal:  Arch Neurol       Date:  2008-09-08
View more
  3 in total

1.  Longitudinal Changes in Retinal Nerve Fibre Layer Thickness after an Isolated Unilateral Retrobulbar Optic Neuritis: 1-Year Results.

Authors:  Gordon S K Yau; Jacky W Y Lee; Patrick P K Lau; Victor T Y Tam; Winnie W Y Wong; Can Y F Yuen
Journal:  Neuroophthalmology       Date:  2015-01-22

2.  Clinical characteristics of optic neuritis in Hong Kong population: 10-year review.

Authors:  Bonnie Nga Kwan Choy; Alex Lap Ki Ng; Jimmy Shiu Ming Lai
Journal:  Int Ophthalmol       Date:  2017-03-13       Impact factor: 2.031

3.  Change of Th17 Lymphocytes and Treg/Th17 in Typical and Atypical Optic Neuritis.

Authors:  Hengri Cong; Hanqiu Jiang; Jingting Peng; Shilei Cui; Lijuan Liu; Jiawei Wang; Xiaojun Zhang
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.